Welcome to Markets Desk, your midday read on what's moving.
BP is flagging up to four point five billion dollars in impairment charges for the third quarter, a significant write-down that signals the energy giant is reassessing asset values across its portfolio. The company updated its upstream production outlook but held firm on its full-year two thousand twenty six guidance, offering investors some anchor against the turbulence.
Shifting to small-cap health, ImmuCell Corporation is turning heads after reporting preliminary third-quarter sales growth of forty-six percent. The animal health biologics firm saw its stock climb on the back of those unaudited figures, a reminder that meaningful earnings momentum can emerge well outside the mega-cap universe when the underlying product cycle is working.
And on the Social Security front, the two thousand twenty seven cost-of-living adjustment is set to be announced tomorrow, and expectations are running cautious. With inflation having moderated considerably from its recent peaks, seniors and analysts alike are bracing for a notably smaller adjustment than the outsized increases seen in recent years, which could weigh on consumer spending among retirees heading into next year.
That's the tape. Markets Desk, signing off the floor.
